Tesamorelin

Product Description Tesamorelin is a synthetic 44-amino acid analogue of growth hormone-releasing hormone (GHRH) that stimulates the endogenous release of growth hormone (GH) from the pituitary gland. Supplied as ≥98% pure lyophilized powder (HPLC/MS verified), it is designed for laboratory studies on growth hormone regulation, visceral fat metabolism, body composition, and related endocrine pathways.

Key Research Mechanism Tesamorelin binds to GHRH receptors on somatotroph cells in the anterior pituitary, triggering pulsatile GH secretion and subsequent elevation of IGF-1 levels. This promotes lipolysis (especially visceral adipose tissue), protein synthesis, and metabolic effects with high specificity while preserving natural GH pulsatility.

Primary Research Areas

• Growth hormone release and pituitary axis studies
• Visceral fat reduction and body composition research
• Metabolic health, lipid metabolism, and insulin sensitivity models
• Muscle preservation, recovery, and age-related endocrine decline

Intended Use For in vitro and in vivo research only. Not for human or veterinary use. This product is sold strictly for scientific and laboratory investigation. Researchers must follow all institutional and regulatory guidelines. Not evaluated by the FDA.